Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACYCLOVIR vs ADALIMUMAB-AFZB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACYCLOVIR vs ADALIMUMAB-AFZB: Safety Overview

Metric ACYCLOVIR ADALIMUMAB-AFZB
Total FAERS Reports 14,197 2,091
Deaths Reported 2,057 101
Death Rate 14.5% 4.8%
Hospitalizations 6,095 374
Average Patient Age 50.0 yrs 49.7 yrs
% Female Patients 51.8% 62.7%
FDA Approval Date Apr 12, 2013 N/A
Manufacturer REMEDYREPACK INC. Pfizer Laboratories Div Pfizer Inc
Route ORAL N/A
Marketing Status Discontinued Prescription